LUMC0053iSCN01B

General

Cell Line

hPSCreg name LUMCi040-A
Cite as:
LUMCi040-A (RRID:CVCL_D0XM)
Alternative name(s)
LUMC0053iSCN01B
Cell line type Human induced pluripotent stem cell (hiPSC)
Similar lines
UKKi024-A
(NP0133-5)
Donor diseases:
Brugada syndrome
IDIBGIi003-A
(​RB20235)
Donor diseases:
Brugada syndrome
UKKi024-B
(NP0133-1)
Donor diseases:
Brugada syndrome
UKKi024-C
(NP0133-4)
Donor diseases:
Brugada syndrome
UKKi030-A
(NP0134-6D)
Donor's gene variants:
SCN5A
Donor diseases:
Brugada syndrome
UKKi030-B
(NP0134-18A)
Donor's gene variants:
SCN5A
Donor diseases:
Brugada syndrome
UKKi030-C
(NP0134-26B)
Donor's gene variants:
SCN5A
Donor diseases:
Brugada syndrome
MRIi017-A
(TRPM4)
Donor diseases:
Brugada syndrome
IDIBGIi002-A
(RB20234)
Donor diseases:
Brugada syndrome
IDIBGIi004-A
(RB20236)
Donor diseases:
Brugada syndrome
NUIGi010-A
(LQTS009C2)
Donor diseases:
Long QT Syndrome 1
NUIGi010-B
(LQTS009C3)
Donor diseases:
Long QT Syndrome 1
NUIGi010-C
(LQTS009Cx)
Donor diseases:
Long QT Syndrome 1
HDZi001-A
(hiPSC NP0039)
Donor's gene variants:
TMEM43
Donor diseases:
arrhythmogenic right ventricular dysplasia 5
NUIGi006-A
(LQTS005C2, LQT005C2)
Donor diseases:
Long QT Syndrome 1
NUIGi006-B
(LQTS005C4, LQT005C4)
Donor diseases:
Long QT Syndrome 1
NUIGi006-C
(LQTS005Cx, LQT005Cx)
Donor diseases:
Long QT Syndrome 1
NUIGi007-A
(LQTS006C6, LQT006C6)
Donor diseases:
Long QT Syndrome 1
NUIGi007-B
(LQTS006C8, LQT006C8)
Donor diseases:
Long QT Syndrome 1
NUIGi009-B
(LQTS008C6)
Donor diseases:
Long QT Syndrome 1
NUIGi009-C
(LQTS008Cx)
Donor diseases:
Long QT Syndrome 1
NUIGi011-A
(LQTS010C3)
Donor diseases:
Long QT Syndrome 1
NUIGi011-B
(LQTS010C4)
Donor diseases:
Long QT Syndrome 1
NUIGi011-C
(LQTS010Cx)
Donor diseases:
Long QT Syndrome 1
NUIGi012-A
(LQT011C8)
Donor diseases:
Long QT Syndrome 2
NUIGi015-A
(LQT014C7)
Donor diseases:
Long QT Syndrome 3
NUIGi015-B
(LQT014C9)
Donor diseases:
Long QT Syndrome 3
NUIGi015-C
(LQT014C12)
Donor diseases:
Long QT Syndrome 3
NUIGi020-A
(LQT019C1)
Donor diseases:
Long QT Syndrome 2
NUIGi020-B
(LQT019C4)
Donor diseases:
Long QT Syndrome 2
NUIGi020-C
(LQT019Cx)
Donor diseases:
Long QT Syndrome 2
NUIGi003-A
(LQT002C1)
Donor diseases:
Long QT Syndrome 2
NUIGi004-A
(LQT003C1)
Donor diseases:
long QT syndrome 2
NUIGi005-A
(LQTS004C7, LQT004C7)
Donor diseases:
Long QT Syndrome 1
NUIGi005-B
(LQTS004C9, LQT004C9)
Donor diseases:
Long QT Syndrome 1
NUIGi005-C
(LQTS004Cx, LQT004Cx)
Donor diseases:
Long QT Syndrome 1
NUIGi008-A
(LQTS007C1)
Donor diseases:
Long QT Syndrome 1
NUIGi003-B
(LQT002C2)
Donor diseases:
Long QT Syndrome 2
NUIGi008-B
(LQTS007C2)
Donor diseases:
Long QT Syndrome 1
NUIGi008-C
(LQTS007Cx)
Donor diseases:
Long QT Syndrome 1
NUIGi009-A
(LQTS008C1)
Donor diseases:
Long QT Syndrome 1
CSSi007-A
(Joub07 cl1, COR11-NG708)
Donor diseases:
Joubert syndrome
LVPEIi007-B
(LVIP04-SD1-1)
Donor diseases:
Stargardt disease
LVPEIi008-B
(LVIP04-SD1-2)
Donor diseases:
Stargardt disease
Last update 8th June 2023
User feedback
No feedback available yet.

Login to share your feedback, experiences or results with the research community.

Provider

Generator Leiden University Medical Center (LUMC)
Owner LUMC hiPSC core facility
Derivation country Netherlands

External Databases

BioSamples SAMEA8359793
Cellosaurus CVCL_D0XM
Wikidata Q123032984

General Information

Projects
* Is the cell line readily obtainable for third parties?
No

Donor Information

General Donor Information

Sex male

Phenotype and Disease related information (Donor)

Diseases A disease was diagnosed.
The donor is a carrier of a disease-associated mutation and affected.
Synonyms
  • Idiopathic ventricular fibrillation, Brugada type

Karyotyping (Donor)

Has the donor karyotype been analysed?
Unknown

Other Genotyping (Donor)

Is there genome-wide genotyping or functional data available?
No

External Databases (Donor)

BioSamples SAMEA8359794

Ethics

Has informed consent been obtained from the donor of the embryo/tissue from which the pluripotent stem cells have been derived? Yes
Was the consent voluntarily given? Yes
Has the donor been informed that participation will not directly influence their personal treatment? Yes
Can you provide us with a copy of the Donor Information Sheet provided to the donor? Yes
Do you (Depositor/Provider) hold the original Donor Consent Form? No
If you do not hold the Donor Consent Form, do you know who does? Yes
Please provide the contact information Dr. Arthur Wilde Amsterdam Academic Center
Is there other documentation provided to the donor for consenting purposes? No
Confirm that consent was obtained by a qualified professional Yes
Has the donor agreed to be re-contacted? Unknown
Has the donor been informed about how her/his data will be protected? Yes
Please indicate whether the data associated with the donated material has been pseudonymised or anonymised. pseudonymised
Does consent explicitly allow the derivation of pluripotent stem cells? Yes
Does consent expressly prevent the derivation of pluripotent stem cells? No
Does consent expressly prevent development of commercial products? No
Does consent expressly prevent financial gain from any use of the donated embryo/tissue, including any product made from it? No
Does consent expressly permit storage of donated embryo/tissue for an unlimited time? No
Does consent expressly permit storage of cells derived from the donated embryo/tissue for an unlimited time? No
Does consent prevent the DONATED BIOSAMPLE from being made available to researchers anywhere in the world? No
Does consent prevent CELLS DERIVED FROM THE DONATED BIOSAMPLE from being made available to researchers anywhere in the world? No

Does consent permit research by

an academic institution? Yes
Does consent expressly permit collection of genetic information? Yes
Does consent expressly permit storage of genetic information? Yes
Does consent prevent dissemination of genetic information? No
Has the donor consented to receive information discovered during use of donated embryo/tissue that has significant health implications for the donor? Yes
How may genetic information associated with the cell line be accessed? Controlled Access
Will the donor expect to receive financial benefit, beyond reasonable expenses, in return for donating the biosample? No
Does the consent anticipate that the donor will be notified of results or outcomes of any research involving the donated samples or derived cells? No
Does the consent permit the donor, upon withdrawal of consent, to stop the use of the derived cell line(s) that have already been created from donated samples? No
Does the consent permit the donor, upon withdrawal of consent, to stop delivery or use of information and data about the donor? No
Has a favourable opinion been obtained from a research ethics committee, or other ethics review panel, in relation to the Research Protocol including the consent provisions? Yes
Name of accrediting authority involved? Medisch Ethische Toetsingscommissie
Approval number NL30225.018.09
Has a favourable opinion been obtained from a research ethics committee, or other ethics review panel, in relation to the PROPOSED PROJECT, involving use of donated embryo/tissue or derived cells? Yes
Name of accrediting authority involved? Medisch Ethische Toetsingscommissie
Approval number NL30225.018.09
Do you have obligations to third parties in regard to the use of the cell line? No
Are you aware of any further constraints on the use of the donated embryo/tissue or derived cells? No
Is there an MTA available for the cell line? No
For generation of the cell line, who was the supplier of any recombined DNA vectors or commercial kits used?
Are you aware of any constraints on the use or distribution of the cell line from the owner or any parties identified in the query above? No

hIPSC Derivation

General

Source cell type
Dermal fibroblasts are the major cell type in dermis and are commonly accepted as terminally differentiated cells.
Source cell origin
An organ that constitutes the external surface of the body. It consists of the epidermis, dermis, and skin appendages.
Synonyms
  • Skin
  • Human Skin
  • SKIN
  • Integument
  • Skin, total
  • Skin, NOS
  • Skin structure (body structure)
  • entire skin
  • skin of body
  • skin organ
show more synonyms

Reprogramming method

Vector type Non-integrating
Vector Sendai virus
Is reprogramming vector detectable?
No
Methods used
Immunostaining, RT-PCR

Vector free reprogramming

Other

Selection criteria for clones morphology and growth rate
Derived under xeno-free conditions
No
Derived under GMP?
No
Available as clinical grade?
No

Culture Conditions

Surface coating Matrigel/Geltrex
Feeder cells
No
Passage method Mechanically
Medium mTeSR™ 1
Has Rock inhibitor (Y27632) been used at passage previously with this cell line?
Yes
Has Rock inhibitor (Y27632) been used at cryo previously with this cell line?
Yes
Has Rock inhibitor (Y27632) been used at thaw previously with this cell line?
Yes

Characterisation

Analysis of Undifferentiated Cells
Marker Expressed Immunostaining RT-PCR Flow Cytometry Enzymatic Assay Expression Profiles
NANOG
Yes
SSEA-4
Yes
POU5F1 (OCT-4)
Yes
Differentiation Potency
Endoderm
Ont Id: UBERON_0000925
In vitro spontaneous differentiation
Marker Expressed
AFP
Yes
Morphology
AFP - endoderm.pdf
AFP (green) DNA (blue)
Mesoderm
Ont Id: UBERON_0000926
In vitro spontaneous differentiation
Marker Expressed
CD31
Yes
Ectoderm
Ont Id: UBERON_0000924
In vitro spontaneous differentiation
Marker Expressed
Beta 3 Tubulin
Yes
Morphology
TUBB3 - ectoderm.pdf
TUBB3 (red) DNA (blue)

Genotyping

Karyotyping (Cell Line)

Has the cell line karyotype been analysed?
Yes
46,XY
Karyotyping method: COBRA-FISH

Other Genotyping (Cell Line)